Capvizr
News · All summaries
Healthcare & Life Sciences
N-Power Medicine
Series B$32 million
RoundSeries B
Amount$32 million
LeadMerck Global Health Innovation Fund
HQRedwood City, United States
DateSeptember 1, 2026
THE DEAL, AT A GLANCE

N-Power Medicine

From the announcement
Who is involvedBacked by Merck Global Health Innovation FundFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedN-Power Medicine raised $32M Series B, announced 2026-09-01From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersN-Power Medicine's Series B is a below-median Healthcare & Life Sciences financing within an active trailing 30-day sector funding window, with the primary signal coming…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

N-Power Medicine · Financing Record

Explore source-linked visual explanations for N-Power Medicine. Unsupported claims are withheld while source review continues.

Record 11466 · Recorded date: 2026-09-01

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime